Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | UNK | X1C891M | OT |
patient was supposed to receive a PPD dose, but received IPOL via subdermal route with no adverse event; patient was supposed to receive a PPD dose, but received IPOL via subdermal route with no adverse event; Initial information received on 24-Feb-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 22 years old female patient who was supposed to receive a ppd dose, but received IPV (VERO) [IPOL] via subdermal route with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Influenza Vaccine and Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular, Tetanus Vaccine Toxoid (TDAP) for Immunisation. On 24-Feb-2025, the patient received a 0.1 ml dose of suspect IPV (VERO) (lot X1C891M , Expiry: 31-Oct-2026, with unknown strength) via subdermal route in the left forearm as Immunization (incorrect route of product administration) but was supposed to receive PPD with no adverse event (wrong product administered) (Latency: same day). Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
INFLUENZA VACCINE; TDAP